MILAN, Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the launch of REPLY CRT-P, its new cardiac resynchronization therapy ...

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced approval from the U.S. Food and Drug Administration (FDA) for the Allure Quadra ™ ...

The average price paid by hospitals for cardiac implantable resynchronization pacemakers has dropped 12% over the last year, according to the most recent Modern Healthcare/ECRI Institute Technology ...

Analysts believe that device makers who are able to launch implantable products whose functioning isn’t hampered by magnetic resonance imaging will win as chronically ill patients are often directed ...

Please provide your email address to receive an email when new articles are posted on . A leadless pacemaker can deliver cardiac resynchronization therapy to patients who cannot have conventional CRT ...

MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...

Biotronik announced that it has launched the smallest MR conditional cardiac resynchronization therapy pacemaker in the U.S., recently approved by the FDA. According to a press release from the ...

Washington, DC - The US Food and Drug Administration has approved two Biotronik cardiac-resynchronization-therapy pacemaker (CRT-P) generators, including one with an integrated home-monitoring system, ...

Pacemakers do not result in lower survival than implantable cardiac defibrillator (ICD) devices in patients undergoing cardiac resynchronization therapy (CRT) for heart failure, a large health claims ...

Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...

St. Jude ($STJ) thinks it has built a better pacemaker, an ongoing obsession of the medical device giants in pursuit of defending their market turf. The company has ...

MILAN--(BUSINESS WIRE)--Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the launch of REPLY CRT ...